Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2012
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148589 Human cancer-related gene, its encoded products and applications
06/14/2012US20120148585 Fusion molecules and methods for treatment of immune diseases
06/14/2012US20120148582 Engineered anti-il-23r antibodies
06/14/2012US20120148580 Methods for identification of sites for igg conjugation
06/14/2012US20120148573 Compositions and methods for the diagnosis and treatment of immune disorders
06/14/2012US20120148572 Novel antibodies
06/14/2012US20120148571 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the ph, compounds comprising the same, and uses thereof
06/14/2012US20120148559 Compositions and method for deimmunization of proteins
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148527 TNF Superfamily Fusion Proteins
06/14/2012US20120148490 Anti-ngf compositions and use thereof
06/14/2012US20120147987 Method and apparatus for data transmission using multiple transmit antennas
06/14/2012US20120145544 Novel ubiquitin ligase and use thereof
06/14/2012DE112010003500T5 Regulatorische Nukleinsäuremoleküle für die Verstärkung der konstitutiven Genexpression in Pflanzen Regulatory nucleic acid molecules for the amplification of the constitutive gene expression in plants
06/14/2012DE112010003389T5 Nematodenresistente transgene Pflanzen Nematode-resistant transgenic plants
06/14/2012DE112009002342T5 Verfahren zum Herstellen einer transgenen Zelle mit erhöhtem Gehalt an gamma-Aminobuttersäure (GABA) A method for producing a transgenic cell with increased content of gamma-aminobutyric acid (GABA)
06/14/2012CA2823673A1 Procedure for determining variants of infectious pancreatic necrosis virus in aquatic animals; associated detection kit; and use of the procedure in aquatic animals
06/14/2012CA2820782A1 Bispecific aptamers mediating tumour cell lysis
06/14/2012CA2820739A1 Microspore transformation methodology by macroinjection
06/14/2012CA2820681A1 Use of chimeric antigen receptor-modified t cells to treat cancer
06/14/2012CA2820671A1 Tnf-.alpha. binding proteins
06/14/2012CA2820630A1 Dimeric molecular complexes with free cysteine residues and conjugates thereof
06/14/2012CA2820444A1 Plant cultivation system utilizing phosphite as a nutrient and as a control agent for weeds and algae
06/14/2012CA2820395A1 Sub-totipotent stem cell product and epigenetic modification label thereof
06/14/2012CA2820134A1 Human monoclonal antibody
06/14/2012CA2820039A1 Immunoassay of cofilin 1 protein
06/14/2012CA2819552A1 Mgmt-based method for obtaining high yield of recombinant protein expression
06/14/2012CA2819038A1 Humanized antibodies to liv-1 and use of same to treat cancer
06/14/2012CA2818997A1 Methods and compositions using small interfering rna (sirna) for nematode control in plants
06/14/2012CA2818913A1 Methods for the production of synthetic promoters with defined specificity
06/14/2012CA2818024A1 Double stranded oligonucleotide compounds comprising positional modifications
06/14/2012CA2817697A1 Methods and devices for nucleic acids synthesis
06/13/2012EP2463660A1 Nucleic acid element for use in analysis, and analytical method, analytical reagent and analytical instrument using same
06/13/2012EP2463381A1 Methods and compositions for the diagnosis and prognosis of cervical intraepithelial neoplasia and cervical cancer
06/13/2012EP2463377A1 Process for production of l-lysine using bacterium belonging to genus vibrio
06/13/2012EP2463374A2 Isolated alcohol dehydrogenase enzymes and uses thereof
06/13/2012EP2463373A2 Gene coding for an auxin receptor protein derived from the rice plant, and applications therefor
06/13/2012EP2463372A1 Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
06/13/2012EP2463371A2 Sirna conjugate and preparation method thereof
06/13/2012EP2463370A1 Use of genetically modified organisms to generate biomass degrading enzymes
06/13/2012EP2463369A1 Humanized anti-amyloid-b oligomer antibody
06/13/2012EP2463368A1 Humanized anti-amyloid-b oligomer antibody
06/13/2012EP2463367A1 Novel ubiquitin ligase and use thereof
06/13/2012EP2463366A1 Novel glycosyltransferase, novel glycosyltransferase gene, and novel glycosyl donor compound
06/13/2012EP2463365A1 Probes for detection of UGT1A1 gene, reagent for detection of UGT1A1 gene comprising the same, and uses thereof
06/13/2012EP2463364A1 High fidelity restriction endonucleases
06/13/2012EP2463363A1 High fidelity restriction endonucleases
06/13/2012EP2463362A1 Simian subfamily c adenovirus SAdv-31 and uses thereof
06/13/2012EP2463302A1 Multivalent immunoglobulins modified in the structural loop region
06/13/2012EP2463298A1 Reproductive ablation constructs
06/13/2012EP2462951A1 Use of two microrna moleculars in lung cancer prognosis and medicine preparation
06/13/2012EP2462948A1 Bacterial virulence factors and uses thereof
06/13/2012EP2462938A1 Anionic polymer, polyion complex using anionic polymer, ternary polymer composite, and pharmaceutical composition
06/13/2012EP2462936A1 SiRNA mediated post-transriptional gene-silencing of genes involved in alopecia
06/13/2012EP2462231A2 Transgenic mouse lacking endogenous fviii and vwf - a model of hemophilia a
06/13/2012EP2462230A2 Methods and compositions for targeted gene modification
06/13/2012EP2462229A2 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
06/13/2012EP2462228A1 Means and methods for counteracting, delaying and/or preventing adverse energy metabolism switches in heart disease
06/13/2012EP2462227A1 Dna loaded supported gold nanoparticles, process for the preparation and use thereof
06/13/2012EP2462226A1 Process and device for collecting nucleic acids of microorganisms from a particulate sample
06/13/2012EP2462225A1 Method of efficiently establishing induced pluripotent stem cells
06/13/2012EP2462220A2 Filamentous fungi and methods for producing trichodiene from lignocellulosic feedstocks
06/13/2012EP2462162A1 Antibodies that specifically bind to a beta oligomers and use thereof
06/13/2012EP2462161A1 Antibodies that specifically bind to a beta oligomers and use thereof
06/13/2012EP2462156A1 Method of producing a sweet protein
06/13/2012EP2461824A1 Immunogenic composition comprising antigenic s. aureus proteins
06/13/2012EP2461819A2 Methods and compositions for treating trinucleotide repeat disorders
06/13/2012EP2461667A2 Transgenic plants having increased biomass
06/13/2012EP2252373B1 Novel fer -like protein, pharmaceutical compositions containing it and method for its use
06/13/2012EP2124548B1 Disintegrin variants and pharmaceutical uses thereof
06/13/2012EP2094842B1 Novel laccases, compositions and methods of use
06/13/2012EP2081954B1 Methods for increasing the resistance of plants to fungi
06/13/2012EP1969125B1 Micrornas that regulate muscle cell proliferation and differentiation
06/13/2012EP1874811B1 Methods for modulating bone formation and mineralization by modulating KRC activity
06/13/2012EP1869187B1 Elite event a2704-12 and methods and kits for identifying such event in biological samples
06/13/2012EP1842558B1 Composition for inhibiting expression of target gene
06/13/2012EP1828390B1 Chimeric vectors
06/13/2012EP1812570B1 Improved treatment of cancer using tlr3 agonists
06/13/2012EP1748062B1 Succinic acid-producing bacterium and process for producing succinic acid
06/13/2012EP1694847B1 Serine proteases, nucleic acids encoding serine enzymes and vectors and host cells incorporating same
06/13/2012EP1678202B1 Hcv ns3-ns4a protease resistance mutants
06/13/2012EP1619248B1 Mouse with deficiency of glutamate transporter glast function
06/13/2012EP1597382B1 Genetically modified non-human mammals and cells
06/13/2012EP1571209B1 Method of detecting target base sequence of rna interference, method of designing polynucleotide base sequence causing rna interference, method of constructing double-stranded polynucleotide, method of regulating gene expression, base sequence processing apparatus, program for running base sequence
06/13/2012EP1546339B1 Rotatable cutting tool
06/13/2012EP1516058B1 Recombinant measles viruses expressing epitopes of antigens of rna viruses and use of the recombinant viruses for the preparation of vaccine compositions
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1494697B1 Monomeric and dimeric fluorescent protein variants and methods for making same
06/13/2012EP1490110B1 Anti-alpha v beta 6 antibodies
06/13/2012EP1478761B1 Degradation of hydrophobic ester pesticides and toxins
06/13/2012EP1459070B1 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers
06/13/2012EP1442057B1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1409646B1 Transgenic animals comprising a humanized immune system
06/13/2012EP1379535B1 Expression vectors able to elicit improved immune response and methods of using same
06/13/2012EP1327005B1 Method for selecting nucleic acids that bond with high-affinity to a target
06/13/2012EP1183338B2 Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98
06/13/2012EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa
06/13/2012EP0451216B2 Humanized immunoglobulins and their production and use
1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 4023